Abstract
Open questions in haemophilia, such as effectiveness of innovative therapies, clinical and patient-reported outcomes (PROs), epidemiology and cost, await answers. The aim was to identify data attributes required and investigate the availability, appropriateness and accessibility of real-world data (RWD) from German registries and secondary databases to answer the aforementioned questions. Systematic searches were conducted in BIOSIS, EMBASE and MEDLINE to identify non-commercial secondary healthcare databases and registries of patients with haemophilia (PWH). Inclusion of German patients, type of patients, data elements-stratified by use in epidemiology, safety, outcomes and health economics research-and accessibility were investigated by desk research. Screening of 676 hits, identification of four registries [national PWH (DHR), national/international paediatric (GEPARD, PEDNET), international safety monitoring (EUHASS)] and seven national secondary databases. Access was limited to participants in three registries and to employees in one secondary database. One registry asks for PROs. Limitations of secondary databases originate from the ICD-coding system (missing: severity of haemophilia, presence of inhibitory antibodies), d...Continue Reading
References
Sep 25, 2007·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Louis P GarrisonC Daniel Mullins
Jan 18, 2008·Pharmacoepidemiology and Drug Safety·Iris Pigeot, Wolfgang Ahrens
Jan 5, 2011·Thrombosis Research·M MakrisP M Mannucci
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·John F P BridgesJosephine Mauskopf
Dec 14, 2011·Haemophilia : the Official Journal of the World Federation of Hemophilia·S GuhJ M Soucie
May 3, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·K FischerH M van den Berg
Aug 30, 2014·Journal of Internal Medicine·M Osooli, E Berntorp
Jan 4, 2015·BMJ : British Medical Journal·Larissa ShamseerUNKNOWN PRISMA-P Group
Feb 12, 2015·Clinical Pharmacology and Therapeutics·C KeipertUNKNOWN ABIRISK Consortium
Jan 27, 2016·European Journal of Haematology·Gerry DolanRiitta Lassila
Mar 16, 2016·International Journal of Technology Assessment in Health Care·Alina BrandesWolf H Rogowski
Mar 22, 2016·Journal of Internal Medicine·M Osooli, E Berntorp
Apr 21, 2016·Seminars in Thrombosis and Hemostasis·Erik Berntorp, Nadine G Andersson
Jun 21, 2016·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Elisabeth George
Aug 27, 2016·American Journal of Hematology·Jan Hartmann, Stacy E Croteau
Dec 19, 2016·Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen·Jonas CzwiklaKlaus Giersiepen
Jun 2, 2017·Orphanet Journal of Rare Diseases·Jamie O'HaraDaniel-Anibal Garcia Diego
Jun 3, 2017·Haemophilia : the Official Journal of the World Federation of Hemophilia·A ShresthaK Batt